Search
Search
About
Log in
Join
Experiences with
Farydak
Posts
Communities
1 public post
Filter results
MPN News for treatment primary myelofibrosis, post-PVMF, Post ET-MF and Primary myelofibrosis
The combination of panobinostat (
Farydak
) and ruxolitinib (Jakafi) demonstrated efficacy and a tolerable safety profile as a treatment for patients with primary myelofibrosis (PMF) and post-polycythemia vera–related myelofibrosis (post-PV MF), and post-essential thrombocythemia–related myelofibrosis
The combination of panobinostat (
Farydak
) and ruxolitinib (Jakafi) demonstrated efficacy and a tolerable safety profile as a treatment for patients with primary myelofibrosis (PMF) and post-polycythemia vera–related myelofibrosis (post-PV MF), and post-essential thrombocythemia–related myelofibrosis
mammared
in
MPN Voice
5 years ago
Want to take advantage of all our features? Just log in!
Log in
or
Join
Filter results
Clear filters
Posted in
All communities
MPN Voice
1 result
Sort by
Most Relevant
Newest